Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...

But between shortages, high out of pocket costs and the need for weekly injections, the medication is not suited for everyone ...

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...

Obesity has been declared a disease by WHO. It is associated not only with heart disease, diabetes, stroke, gallstones, ...

Novo Nordisk chief financial officer Karsten Munk Knudsen said on Wednesday the company was aware of reports of 10 deaths and ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

Researchers at the University of Copenhagen have identified a promising new drug target for weight loss which could revolutionise treatment for millions of people with obesity and type 2 diabetes. The ...

The government has suggested weight-loss drugs ... Semaglutide is also used in the diabetes treatment Ozempic. Both Wegovy and Mounjaro are given as weekly injections via pre-filled pens that ...

Semaglutide shows promise in treating knee osteoarthritis by reducing pain and weight, offering a safe alternative to ...

While Novo Nordisk and Lilly are the undisputed leaders in weight management right now, a number of pharmaceutical companies ...

The drug semaglutide, sold under the brand name Ozempic for diabetes management and Wegovy for weight ... While it remains ...